<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
    xmlns:content="http://purl.org/rss/1.0/modules/content/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:atom="http://www.w3.org/2005/Atom"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:media="http://search.yahoo.com/mrss/">
<channel>
    
        <item>
            <title>INDIA NEEDS 1.7B COVID VACCINE DOSES FOR ADULTS - The Daily Guardian</title>
            <link>https://latest.thedailyguardian.com/others/india-needs-1-7b-covid-vaccine-doses-for-adults/</link>
            <guid>https://latest.thedailyguardian.com/others/india-needs-1-7b-covid-vaccine-doses-for-adults/</guid>
            <pubDate>November 12, 2020, 8:02 am</pubDate>
            <description><![CDATA[NEW DELHI: The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax and J&amp;J and the earliest efficacy data is expected by the end of November-December 2020 and in the best case, vaccines can be rolled out in January 2021. According to a research by Credit Suisse, India needs about 1.7 billion Covid-19 vaccine [&hellip;]
]]></description>
            <content:encoded><![CDATA[
<p>NEW DELHI: The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax and J&amp;J and the earliest efficacy data is expected by the end of November-December 2020 and in the best case, vaccines can be rolled out in January 2021. According to a research by Credit Suisse, India needs about 1.7 billion Covid-19 vaccine doses to vaccinate majority of its adult population. It targets to administer 400-500 million doses by July 2021.</p>
]]></content:encoded>
            <media:content url="https://latest.thedailyguardian.com/wp-content/uploads/2020/09/Vaccine.jpg" type="image/jpeg" width="1200" height="675"/>
            <dc:creator>Our Bureau</dc:creator>
            <category></category>
        </item>
</channel>
</rss>